Table 1 Clinical information for breast cancer patients.
From: Dynamic culture system advances the applications of breast cancer organoids for precision medicine
Patient number | Age | Pathologic type | Histological grading | Molecular classification | Treatments | Response |
|---|---|---|---|---|---|---|
BC-1 | 54 | IDC | II | Luminal B | Mastectomy, postoperative chemotherapy (pharmorubicin + Cyclophosphamide + Abraxane) | No tumor recurrence detected at one year of follow-up |
BC-2 | 74 | IDC | II | HER2-positive | Mastectomy, postoperative chemotherapy (pharmorubicin + Cyclophosphamide) | No tumor recurrence detected at one year of follow-up |
BC-3 | 49 | IDC | II | Luminal B | Neoadjuvant chemotherapies (pharmorubicin + Cyclophosphamide + Abraxane) | After 6 cycles of treatment, the tumor size from 2.41*1.91 cm to 1.46*1.24 cm |
